BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8687132)

  • 1. Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells.
    Wolff JE; Denecke J; Jürgens H
    Anticancer Res; 1996; 16(2):805-9. PubMed ID: 8687132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone induced partial resistance to methotrexate in C6-glioma cells.
    Wolff JE; Jürgens H
    Anticancer Res; 1994; 14(4A):1585-8. PubMed ID: 7979189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin induces radioprotection in human T98G glioma cells.
    Poppenborg H; Münstermann G; Knüpfer MM; Hotfilder M; Hacker-Klom U; Wolff JE
    Anticancer Res; 1997; 17(2A):1131-4. PubMed ID: 9137460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C6 cells cross-resistant to cisplatin and radiation.
    Poppenborg H; Münstermann G; Knüpfer MM; Hotfilder M; Wolff JE
    Anticancer Res; 1997; 17(3C):2073-7. PubMed ID: 9216666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
    Naumann U; Durka S; Weller M
    Oncogene; 1998 Sep; 17(12):1567-75. PubMed ID: 9794234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro modulation of cisplatin resistance by cytokines.
    Poppenborg H; Knüpfer MM; Galla HJ; Wolff JE
    Cytokine; 1999 Sep; 11(9):689-95. PubMed ID: 10479405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medroxyprogesterone acetate induces c6 glioma chemosensitization via antidepressant-like lysosomal phospholipidosis/myelinosis in vitro.
    Altinoz MA; Gedikoglu G; Sav A; Ozcan E; Ozdilli K; Bilir A; Del Maestro RF
    Int J Neurosci; 2007 Oct; 117(10):1465-80. PubMed ID: 17729157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model.
    Gu YT; Zhang H; Xue YX
    Brain Res; 2007 Aug; 1162():1-8. PubMed ID: 17618607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1.
    Carollo M; Parente L; D'Alessandro N
    Oncol Res; 1998; 10(5):245-54. PubMed ID: 9802059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells.
    Tallen G; Riabowol K; Wolff JE
    Anticancer Res; 2003; 23(2B):1631-5. PubMed ID: 12820433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
    Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
    Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Gamma Knife surgery on C6 glioma in combination with adenoviral p53 in vitro and in vivo.
    Xu D; Jia Q; Li Y; Kang C; Pu P
    J Neurosurg; 2006 Dec; 105 Suppl():208-13. PubMed ID: 18503358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
    Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
    Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple drug-resistant C6 glioma cells cross-resistant to irradiation.
    Denecke J; Fiedler K; Hacker-Klom U; Mölenkamp G; Jürgens H; Wolff JE
    Anticancer Res; 1997; 17(6D):4531-4. PubMed ID: 9494563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin (CDDP)-induced radiation resistance is not associated with CDDP resistance in 86HG39 and A172 malignant glioma cells.
    Poppenborg H; Knüpfer MM; Preiss R; Wolff JE; Galla HJ
    Eur J Cancer; 1999 Jul; 35(7):1150-4. PubMed ID: 10533462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro.
    Knüpfer MM; Hernáiz-Driever P; Poppenborg H; Wolff JE; Cinatl J
    Anticancer Res; 1998; 18(5A):3585-9. PubMed ID: 9858943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition and differentiation of C6 glioma cells on treatment with hmba.
    Shirsat NV; Kayal JJ; Shaikh S; Mehta A
    Cell Biol Int; 2001; 25(7):621-7. PubMed ID: 11448101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rat model for the multidrug resistant glioma cell line].
    Zhang J; Zhang QL; Wang CW; Yu TF; Guo H; Kong JX; Tao RJ; Liu FS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):43-6. PubMed ID: 15052773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.